SCNX - Scienture Holdings, Inc.
0.417
-0.036 -8.513%
Share volume: 521,947
Last Updated: 03-27-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.45
-0.04
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 06-26-2024 | 08-09-2024 | 11-06-2024 | 03-26-2025 | 05-12-2025 | 08-12-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 18.699 K | 64.861 K | 53.083 K | 10.258 K | 0.000 | 590.050 K | |
| Cost of revenue | 0.000 | 19.402 K | 60.978 K | 50.258 K | 9.585 K | 0.000 | 15.429 K | |
| Gross profit | 0.000 | -703.000 | 3.883 K | 2.825 K | 673.000 | 0.000 | 574.621 K | |
| inf% | 652.35% | -27.25% | -76.18% | -100.00% | inf% | |||
| Operating expenses | 4.880 M | 924.557 K | 2.016 M | 1.569 M | 2.343 M | 3.981 M | 3.656 M | |
| Selling general and admin | 4.880 M | 924.557 K | 762.013 K | 1.569 M | 1.769 M | 3.138 M | 3.486 M | |
| Research and development | 0.000 | 0.000 | 1.254 M | 0.000 | 574.679 K | 843.549 K | 169.344 K | |
| Total expenses | 5.496 M | 1.495 M | 3.502 M | 4.214 M | 3.572 M | 5.158 M | 4.936 M | |
| -72.80% | 134.23% | 20.34% | -15.23% | 44.40% | -4.31% | |||
| Operating income | -5.496 M | -1.496 M | -3.498 M | -4.211 M | -3.571 M | -5.158 M | -4.361 M | |
| Ebit | -6.601 M | -1.661 M | -2.996 M | -6.321 M | -2.419 M | -6.130 M | -1.805 M | |
| Pretax income | -6.637 M | -1.625 M | -3.184 M | -7.334 M | -3.064 M | -6.721 M | -3.607 M | |
| -75.52% | 95.95% | 130.36% | -58.22% | 119.34% | -46.32% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 21.246 M | -1.834 M | -3.184 M | -7.163 M | -3.064 M | -6.721 M | -3.607 M | |
| -108.63% | -73.60% | -124.99% | 57.22% | -119.34% | 46.32% |